Louis C. Bock

This profile gathers the share dealings of Louis C. Bock across 4 companies, led by Orexigen Therapeutics, Inc., Zogenix, Inc. and SGX Pharmaceuticals, Inc. Between 6 February 2006 and 12 March 2018, the trades on record add up to 148 filings.

On the open market, the record shows 9 purchases worth €13.6M and 119 sales worth €1.8M. Purchases outweigh sales by €11.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 8 option exercises. In 2018 alone, the filings show no purchases and 1 sale.

The median purchase comes to €1.8M.

On 14 March 2018 came the latest disclosure, an option exercise for €79k in Zogenix, Inc. The latest purchase dates back some time: it was published 4,371 days ago, on 20 November 2014. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.